🇺🇸 FDA
Pipeline program

Analogs, Prostaglandin E1

CEIS-2020-089

Phase 2 small_molecule terminated

Quick answer

Analogs, Prostaglandin E1 for Covid19 is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
Covid19
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials